Scancell Holdings plc
corporate_fare Company Profile
Scancell Holdings plc (OTC:SCNLD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for SCNLD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 8/10. Recent SEC coverage for SCNLD spans F-4/A.
Recent high-impact activity:
- Scancell Files Amended F-4 for Neuphoria Merger; Exchange Ratio Set at ~0.37725 ADS per Share
Short Interest & Short Volume
88.40 days to coverFINRA reported short interest of 49,856 shares in SCNLD as of the October 30, 2026 settlement, a 88.0% decrease from the prior period — about 88.4 days to cover at its recent average daily volume. On November 17, 2026, 100.0% of SCNLD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
SCNLD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.